United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2016_register
executive
2016-04-29
article
Prospective Grant of Exclusive License: AAV-Mediated Aquaporin Gene Transfer To Treat Sjögren's Syndrome
Notices
D09002ee1c2bb6606
D09002ee1c2bb6693
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
National Institutes of Health
originator
org
United States Government Agency or Subagency
This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive license to MeiraGTx, having a principal place of business in New York, New York, U.S.A. to practice the inventions embodied in the following patent applications, entitled ``AAV-mediated aquaporin gene transfer to treat Sj[ouml]gren's syndrome'':
81 FR 25683
https://www.govinfo.gov/app/details/FR-2016-04-29/2016-09978
2016-09978
fr29ap16-76
4140-01-P
https://www.govinfo.gov/app/details/FR-2016-04-29/2016-09978
https://www.govinfo.gov/content/pkg/FR-2016-04-29/html/2016-09978.htm
https://www.govinfo.gov/content/pkg/FR-2016-04-29/pdf/2016-09978.pdf
1 p.
25683
25683
81 FR 25683
Prospective Grant of Exclusive License: AAV-Mediated Aquaporin Gene Transfer To Treat Sjögren's Syndrome; Federal Register Vol. 81, Issue
NOTICE
2016-09978
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
2016-05-16
4140-01-P
2016-09978
Notice.
This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive license to MeiraGTx, having a principal place of business in New York, New York, U.S.A. to practice the inventions embodied in the following patent applications, entitled ``AAV-mediated aquaporin gene transfer to treat Sj[ouml]gren's syndrome'':
Only written comments and/or applications for a license that are received by the National Institute of Dental and Craniofacial Research, Office of Technology Transfer and Innovation Access on or before May 16, 2016 will be considered.
Requests for a copy of the patent application(s), inquiries, comments and other materials relating to the contemplated license should be directed to: Sally Hu, Ph.D., M.B.A., Senior Licensing and Patenting Manager, Office of Technology Transfer and Innovation Access, National Institute of Dental and Craniofacial Research, National Institutes of Health, BLDG 1 DEM, RM667, 6701 Democracy Blvd., Bethesda, MD 20817; Telephone: (301) 594-2616; Facsimile: (301) 496-1005; Email: sally.hu@nih.gov. A signed confidential disclosure agreement may be required to receive copies of the patent application assuming it has not already been published under the publication rules of either the United States Patent and Trademark Office or the World Intellectual Property Organization.
Prospective Grant of Exclusive Licenses:
AAV-Mediated Aquaporin Gene Transfer to Treat Sjogren's Syndrome
,
sally.hu@nih.gov
Federal Register
Vol. 81, no. 83
Office of the Federal Register, National Archives and Records Administration
2016-04-29
continuing
daily
deposited
born digital
513 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2016-04-29
P0b002ee18f51c60f
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr29ap16
https://www.govinfo.gov/app/details/FR-2016-04-29
https://www.govinfo.gov/content/pkg/FR-2016-04-29/pdf/FR-2016-04-29.pdf
https://www.govinfo.gov/content/pkg/FR-2016-04-29/xml/FR-2016-04-29.xml
fdlp
25585
26088
DGPO
2016-04-29
2023-12-07
FR-2016-04-29
machine generated
eng
FR
FR-2016-04-29
81
83